Cargando…
Human Immune System Increases Breast Cancer-Induced Osteoblastic Bone Growth in a Humanized Mouse Model without Affecting Normal Bone
Bone metastases are prevalent in many common cancers such as breast, prostate, and lung cancers, and novel therapies for treating bone metastases are needed. Human immune system-engrafted models are used in immuno-oncology (IO) studies for subcutaneous cancer cell or patient-derived xenograft implan...
Autores principales: | Kähkönen, Tiina E., Suominen, Mari I., Mäki-Jouppila, Jenni H. E., Halleen, Jussi M., Tanaka, Azusa, Seiler, Michael, Bernoulli, Jenni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532310/ https://www.ncbi.nlm.nih.gov/pubmed/31211147 http://dx.doi.org/10.1155/2019/4260987 |
Ejemplares similares
-
Osteoimmuno-Oncology: Therapeutic Opportunities for Targeting Immune Cells in Bone Metastasis
por: Kähkönen, Tiina E., et al.
Publicado: (2021) -
Immunotherapies and Metastatic Cancers: Understanding Utility and Predictivity of Human Immune Cell Engrafted Mice in Preclinical Drug Development
por: Kähkönen, Tiina E., et al.
Publicado: (2020) -
Insights into immuno-oncology drug development landscape with focus on bone metastasis
por: Kähkönen, Tiina E., et al.
Publicado: (2023) -
Dovitinib dilactic acid reduces tumor growth and tumor-induced bone changes in an experimental breast cancer bone growth model
por: Kähkönen, Tiina E., et al.
Publicado: (2019) -
Endothelial-to-osteoblast transition in normal mouse bone development
por: Lin, Song-Chang, et al.
Publicado: (2023)